🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the producers of acetaminophen, asserting the companies hid potential risks that the drug created to pediatric cognitive development.

The lawsuit comes thirty days after Donald Trump publicized an unproven link between using acetaminophen - referred to as paracetamol - throughout gestation and autism spectrum disorder in children.

Paxton is suing Johnson & Johnson, which once produced the medication, the sole analgesic suggested for pregnant women, and the current manufacturer, which now manufacturers it.

In a official comment, he claimed they "misled consumers by gaining financially from discomfort and promoting medication without regard for the risks."

Kenvue states there is insufficient reliable data linking acetaminophen to autism spectrum disorder.

"These companies lied for decades, deliberately risking numerous people to line their pockets," the attorney general, a Republican, stated.

The manufacturer said in a statement that it was "seriously troubled by the spread of false claims on the safety of acetaminophen and the potential impact that could have on the well-being of US mothers and children."

On its online platform, the company also said it had "regularly reviewed the applicable studies and there is insufficient valid information that demonstrates a established connection between consuming paracetamol and autism spectrum disorder."

Groups speaking for doctors and medical practitioners concur.

The American College of Obstetricians and Gynecologists has stated paracetamol - the main ingredient in acetaminophen - is one of the few options for pregnant women to manage discomfort and fever, which can present major wellness concerns if left untreated.

"In over twenty years of studies on the use of paracetamol in gestation, not a single reputable study has conclusively proven that the use of paracetamol in any period of pregnancy leads to brain development issues in offspring," the organization said.

The court filing cites recent announcements from the Trump administration in asserting the drug is potentially dangerous.

Recently, Trump generated worry from medical authorities when he told pregnant women to "fight like hell" not to consume Tylenol when sick.

Federal regulators then published an announcement that physicians should contemplate reducing the consumption of Tylenol, while also mentioning that "a direct connection" between the medication and autism in young ones has not been established.

Health Secretary Kennedy, who oversees the FDA, had pledged in April to undertake "comprehensive study program" that would establish the origin of autism spectrum disorder in a short period.

But authorities advised that finding a unique factor of autism spectrum disorder - considered by experts to be the result of a complex mix of inherited and surrounding conditions - would prove challenging.

Autism is a category of enduring cognitive variation and disability that impacts how persons perceive and relate to the world, and is diagnosed using doctors' observations.

In his legal document, Paxton - a Trump ally who is running for the Senate - claims the manufacturer and J&J "willfully ignored and sought to suppress the science" around paracetamol and autism spectrum disorder.

This legal action attempts to require the firms "destroy any marketing or advertising" that asserts acetaminophen is secure for expectant mothers.

The court case echoes the concerns of a assembly of parents of minors with autism and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in 2022.

Judicial authorities dismissed the lawsuit, stating studies from the plaintiffs' authorities was not conclusive.